製品の概要

  • 製品名Anti-CHRND antibody
    CHRND 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to CHRND
  • アプリケーション適用あり: ELISA, WB, IHC-Pmore details
  • 種交差性
    交差種: Human
    交差が予測される動物種: Rat, Cow, Dog
  • 免疫原

    Synthetic peptide derived from a region between residues 6-55 of human Acetylcholine Receptor Protein delta Precursor. (the amino acid sequence is considered to be commercially sensitive)

  • ポジティブ・コントロール
    • Jurkat cell lysate (WB), Human Kidney (IHC)

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term.
  • バッファーPreservative: None
    Constituents: 2% Sucrose, PBS
  • Concentration information loading...
  • 精製度Immunogen affinity purified
  • ポリ/モノポリクローナル
  • アイソタイプIgG
  • 研究分野

アプリケーション

Our Abpromise guarantee covers the use of ab26095 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ELISA 1/62500.
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 59 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
IHC-P Use at an assay dependent concentration.

ターゲット情報

  • 機能After binding acetylcholine, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane.
  • 関連疾患Defects in CHRND are a cause of multiple pterygium syndrome lethal type (MUPSL) [MIM:253290]. Multiple pterygia are found infrequently in children with arthrogryposis and in fetuses with fetal akinesia syndrome. In lethal multiple pterygium syndrome there is intrauterine growth retardation, multiple pterygia, and flexion contractures causing severe arthrogryposis and fetal akinesia. Subcutaneous edema can be severe, causing fetal hydrops with cystic hygroma and lung hypoplasia. Oligohydramnios and facial anomalies are frequent.
    Defects in CHRND are a cause of congenital myasthenic syndrome slow-channel type (SCCMS) [MIM:601462]. SCCMS is the most common congenital myasthenic syndrome. Congenital myasthenic syndromes are characterized by muscle weakness affecting the axial and limb muscles (with hypotonia in early-onset forms), the ocular muscles (leading to ptosis and ophthalmoplegia), and the facial and bulbar musculature (affecting sucking and swallowing, and leading to dysphonia). The symptoms fluctuate and worsen with physical effort. SCCMS is caused by kinetic abnormalities of the AChR, resulting in prolonged endplate currents and prolonged AChR channel opening episodes.
    Defects in CHRND are a cause of congenital myasthenic syndrome fast-channel type (FCCMS) [MIM:608930]. FCCMS is a congenital myasthenic syndrome characterized by kinetic abnormalities of the AChR. In most cases, FCCMS is due to mutations that decrease activity of the AChR by slowing the rate of opening of the receptor channel, speeding the rate of closure of the channel, or decreasing the number of openings of the channel during ACh occupancy. The result is failure to achieve threshold depolarization of the endplate and consequent failure to fire an action potential.
  • 配列類似性Belongs to the ligand-gated ion channel (TC 1.A.9) family. Acetylcholine receptor (TC 1.A.9.1) subfamily. Delta/CHRND sub-subfamily.
  • 細胞内局在Cell junction > synapse > postsynaptic cell membrane. Cell membrane.
  • Information by UniProt
  • 参照データベース
  • 別名
    • Acetylcholine receptor delta subunit antibody
    • Acetylcholine receptor subunit delta antibody
    • ACHD_HUMAN antibody
    • ACHRD antibody
    • Cholinergic receptor, nicotinic, delta polypeptide antibody
    • CHRND antibody
    • CMS2A antibody
    • FCCMS antibody
    • Nicotinic acetylcholine receptor delta polypeptide precursor antibody
    • SCCMS antibody
    see all

Anti-CHRND antibody 画像

  • Anti-CHRND antibody (ab26095) (at 1 ug/ml in 5% skim milk / PBS buffer) + Jurkat cell lysate 10ug.

    Secondary
    HRP conjugated anti Rabbit IgG diluted in 1/50,000 - 1/100,000.

    Predicted band size : 59 kDa
  • Ab26095 at a concentration of 4-8ug/ml staining paraffin embedded human kidney tissue by Immunohistochemistry. The arrows indicate the epithelial cells of renal tubule. Magnification: x400.

Anti-CHRND antibody (ab26095) 使用論文

This product has been referenced in:
  • Soeda J  et al. Nicotine induces fibrogenic changes in human liver via nicotinic acetylcholine receptors expressed on hepatic stellate cells. Biochem Biophys Res Commun : (2011). Read more (PubMed: 22108052) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab26095.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"